Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

New treatments are needed for non-scarring alopecia due to current limitations.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Anti-Ku antibodies are linked to unique symptoms and may involve autophagy issues.

High mTORC1 activity slows hair growth and causes it to lose color.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Small molecule treatments improve the ability of human amniotic fluid stem cells to become different cell types.

Induced pluripotent stem cells are a major breakthrough in regenerative medicine.

Gut bacteria may influence hair loss in alopecia areata.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Special cells can help regrow hair in alopecia areata.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Exosome therapy could revolutionize stroke treatment, but more research is needed for human use.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Extracellular vesicles can help repair and regenerate tissues with less risk of rejection.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

COVID-19 pandemic increased alopecia areata cases and hospitalizations.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.